The latest update is out from WuXi XDC Cayman, Inc. ( (HK:2268) ).
WuXi XDC Cayman Inc. has announced a board meeting scheduled for March 24, 2025, to discuss and approve the annual results for the year ending December 31, 2024. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders and market positioning.
More about WuXi XDC Cayman, Inc.
WuXi XDC Cayman Inc. operates in the pharmaceutical industry, focusing on the development and production of biologics and drug conjugates. The company is incorporated in the Cayman Islands and is part of a group with a global market presence.
YTD Price Performance: 4.89%
Average Trading Volume: 5,285,748
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$38.61B
See more data about 2268 stock on TipRanks’ Stock Analysis page.